On January 23, 2018, Thermo Fisher Scientific (TMO) traded at its 52-week high of $217.22. However, it closed at $214.55. It has a 50-day moving average of $196.44 and a 200-day moving average of $188.61. The stock was trading at its 52-week low of $140 per share a year ago on January 24, 2017.
TMO stock fell more than 5% on December 4, 2017, when its target price was lowered by Leerink Swan, citing competition from Amazon as a potential near-term threat. The stock has risen 11.4% since then.
Thermo Fisher Scientific reported its 3Q17 earnings results on October 25, 2017. The results exceeded Wall Street estimates and rose ~3% that day. Triggered by positive investor sentiment, the stock hit its 52-week high the next day on October 26, 2017. Since that day, TMO stock has risen ~7.5%.
Over the last 12 months, TMO stock has risen ~49.5%. Year-to-date, it has risen ~13%. The six-month gain is 17.8%.
Comparisons with industry and market performances
Thermo Fisher Scientific’s stock performance has exceeded the broader market and industry performances over the last year. The stock has had stellar gains driven by its strong fundamentals, strategic launches, partnerships, and earnings results. The S&P 500 Index and the US healthcare industry (XLV) have risen 25% and 27%, respectively, over the last year. TMO also outperformed the US medical device sector (IHI), which has risen 35% over the last 12 months.